NUVL
Nuvalent, Inc.
$123.94
+0.04 (+0.03%)
At close · Jul 13
Market Cap
$9.79B
Shares
78,997,915
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$123.94
Open$123.88
Day$123.87–123.97
52W$71.13–123.97
Avg vol 30d4.1M
Short int2.9M · 3.7% float · 1.2d
Short vol46%
Last earningsMay 27, 2026
DataJul 2021–Jul 2026
Filing10-Q · May 7
Up next
Next earnings call
Oct 28, 2026
Est · unconfirmed
· in 15 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Moderate
Market backdrop
VIX 17.2 · elevated
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+20%
above
Price vs 50-day avg
+11%
above
RSI (14)
68
neutral
MACD trend
Negative
52-week position
100%
near high
Momentum
relative strength
1-month return
0%
trailing
6-month return
+19%
trailing
YTD return
+23%
this year
Relative strength
+11%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $111 › 200d $103 — 50d above 200d
Institutional flow
Accumulating
10 of 263 funds reported for Jun 30 · net +102.2K sh shares · +2 new
Insider flow
Distributing
Net -$12.7M over 90 days · 100% sells
Short interest
Falling
3.68% of float · ▼ -6.7% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
263 holders — near 3-yr high, broad support
Squeeze score
50
elevated · 0–100
Fundamentals
EPS growth
−49%
Y/Y
Balance sheet
$261.7M
net cash
Quant / Vol
risk profile
Volatility
58%
annualized · 1-yr
Max drawdown
−21%
past year
ATR
1.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+20%
Bullish
Price vs 50-day avg
+11%
Bullish
RSI (14)
68
Neutral
MACD trend
Negative
Bearish
52-week position
100%
Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $111 › 200d $103 — 50d above 200d
Institutional flow
Accumulating
10 of 263 funds reported for Jun 30 · net +102.2K sh shares · +2 new
Insider flow
Distributing
Net -$12.7M over 90 days · 100% sells
Short interest
Falling
3.68% of float · ▼ -6.7% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
263 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $71
Now $124 · 100%
52-wk high $124
vs 200-day avg +20%
vs 50-day avg +11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NUVL
this stock
Nuvalent, Inc.
|
$9.79B | +23.2% | — | — | 3.7% |
|
ONC
BeOne Medicines Ltd.
|
$439.30B | +0.0% | +22179.2% | 894.0 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.89B | +5.9% | +46.2% | 28.5 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.52B | -14.0% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.76B | +4.2% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NUVL | +0.2% | +0.4% | +18.9% | +0.4% | +23.2% |
| SPY | -0.3% | +1.6% | +8.3% | +0.3% | +9.9% |
| vs SPY | +0.5% | -1.2% | +10.6% | +0.0% | +13.4% |
Key facts
CIK
1861560
CUSIP
670703107
13F (30d)
13 filings
12 filers
Visit website
Investor relations